 |
|
|
| |
Low Incidence of Treatment-Emergent Resistance to Bictegravir/ Emtricitabine/Tenofovir Alafenamide Under Real-World Adherence Conditions Among People With HIV in the United States, 2018-2024
|
| |
| |
IAS 2026 Rio, Brazil
Sara N Levintow1, Paul McDwyer2, Ziwei Yin2, Wenyi Wang2, Michelle L D’Antoni2, Travis Lim2
1IQVIA, Durham, NC, USA; 2Gilead Sciences, Inc., Foster City, CA, USA
|
| |
|
|
|
|
|
